Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Visit our FAQ page or contact us directly
The molecule is identified in the published clinical-research literature under the development designation LY3437943
The most common ones are gastrointestinal and are often most pronounced during the initial dose-escalation phase
Additionally, evidence from genetic, post-mortem and animal studies over the past decade has identified a number of susceptibility factors for schizophrenia, including neuregulin 1 (Nrg1) and its receptor ErbB4, disrupted-in-schizophrenia-1 (DISK1), dysbindin-1, catechol-O-methyl tranferase (COMT), BDNF, and Akt
US$ 22.73
US$ 21.20
US$ 26.03
US$ 24.84
